# Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept

> **NCT02095418** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 152 (estimated)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Mycophenolate mofetil, Corticosteroids
- **DRUG:** Corticosteroids, Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT02095418
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2014-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02095418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02095418, "Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept". Retrieved via AI Analytics 2026-06-20 from https://api.ai-analytics.org/clinical/NCT02095418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*